Annual report pursuant to Section 13 and 15(d)

[1]	Segment assets have been adjusted for intercompany accounts to reflect actual assets for each segment.
[2]	For 2014, included goodwill impairment charge of $380,000 recorded for the Company's SYA subsidiary (Services Segment) which was divested on July 29, 2014. For 2013, included goodwill impairment charge of $13,691,000 recorded for the Treatment Segment and $14,165,000 recorded for the Services Segment.
[3]	The consolidated revenues included the United States Enrichment Corporation ("USEC") revenues of $10,272,000 or 18.0% and $2,037,000 or 2.7% for the years ended 2014 and 2013, respectively, of our total consolidated revenue from continuing operations and CH Plateau Remediation Company ("CHPRC") revenue of $5,762,000 or 10.1% and $19,922,000 or 26.8%, for the years ended 2014 and 2013, respectively, of our total consolidated revenue from continuing operations.
[4]	Amounts reflect the activity for corporate headquarters and PF Medical S.A. not included in the segment information.
[5]	Amount includes assets from our discontinued operations of $701,000 and $4,481,000, as of December 31, 2014 and 2013, respectively and assets from PF Medical S.A of $1,213,000 and $0 as of December 31, 2014 and 2013, respectively.
[6]	Net of debt discount of ($137,000) and ($223,000) for 2014 and 2013, respectively, based on the estimated fair value at issuance of two Warrants and 90,000 shares of the Company's Common Stock issued on August 2, 2013 in connection with a $3,000,000 promissory note entered into by the Company and Messrs. William Lampson and Robert L. Ferguson. See Note 9 - "Long-Term Debt - Promissory Note and Installment Agreement" for additional information.